Ballentine Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Ballentine Partners’s Portfolio TEVA Stock Details TEVA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$293K	Buy
2017 Q4	–	Sell
2017 Q3	$262K	Sell
2017 Q2	$582K	Buy